The Medicines Company aims to be a leader in the areas of serious infectious disease care, acute cardiovascular care, and surgery and perioperative care. Its marketed products include Angiomax, an anticoagulant used during coronary angioplasties; Cleviprex, an intravenous small molecule calcium channel blocker for blood pressure reduction; and Ionsys for the short-term management of acute postoperative pain. The Medicines Company was founded in 1996 and is based in Parsippany, New Jersey.